Search Results - "Praetz, T"

Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study by Nabieva, N., Fehm, T., Häberle, L., de Waal, J., Rezai, M., Baier, B., Baake, G., Kolberg, H.-C., Guggenberger, M., Warm, M., Harbeck, N., Wuerstlein, R., Deuker, J.-U., Dall, P., Richter, B., Wachsmann, G., Brucker, C., Siebers, J.W., Popovic, M., Kuhn, T., Wolf, C., Vollert, H.-W., Breitbach, G.-P., Janni, W., Landthaler, R., Kohls, A., Rezek, D., Noesselt, T., Fischer, G., Henschen, S., Praetz, T., Heyl, V., Kühn, T., Krauss, T., Thomssen, C., Hohn, A., Tesch, H., Mundhenke, C., Hein, A., Hack, C.C., Schmidt, K., Belleville, E., Brucker, S.Y., Kümmel, S., Beckmann, M.W., Wallwiener, D., Hadji, P., Fasching, P.A.

“…Endocrine treatment (ET) with an aromatase inhibitor (AI) is the treatment of choice in post-menopausal patients with hormone receptor–positive early breast…”
Get full text

Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study by Fasching, P A, Fehm, T, Kellner, S, de Waal, J, Rezai, M, Baier, B, Baake, G, Kolberg, H-C, Guggenberger, M, Warm, M, Harbeck, N, Würstlein, R, Deuker, J-U, Dall, P, Richter, B, Wachsmann, G, Brucker, C, Siebers, J W, Fersis, N, Kuhn, T, Wolf, C, Vollert, H-W, Breitbach, G-P, Janni, W, Landthaler, R, Kohls, A, Rezek, D, Noesslet, T, Fischer, G, Henschen, S, Praetz, T, Heyl, V, Kühn, T, Krauß, T, Thomssen, C, Kümmel, S, Hohn, A, Tesch, H, Mundhenke, C, Hein, A, Rauh, C, Bayer, C M, Jacob, A, Schmidt, K, Belleville, E, Hadji, P, Wallwiener, D, Grischke, E-M, Beckmann, M W, Brucker, S Y

“…The EvaluateTM study (Evaluation of therapy management and patient compliance in postmenopausal hormone receptor-positive breast cancer patients receiving…”
Get full text

Interest in integrative medicine among postmenopausal hormone receptor-positive breast cancer patients receiving letrozole treatment in the EvAluate-TM study by Hack, CC, Fasching, PA, Fehm, T, de Waal, J, Rezai, M, Baier, B, Baake, G, Kolberg, HC, Guggenberger, M, Warm, M, Harbeck, N, Wuerstlein, R, Deuker, JU, Dall, P, Richter, B, Wachsmann, G, Brucker, C, Siebers, JW, Fersis, N, Kuhn, T, Wolf, C, Vollert, HW, Breitbach, GP, Janni, W, Landthaler, R, Kohls, A, Rezek, D, Noesselt, T, Fischer, G, Henschen, S, Praetz, T, Heyl, V, Kühn, T, Krauß, T, Thomssen, C, Hohn, A, Tesch, H, Mundhenke, C, Hein, A, Rauh, C, Bayer, CM, Jacob, A, Schmidt, K, Belleville, E, Hadji, P, Brucker, SY, Wallwiener, D, Paepke, D, Kümmel, S, Beckmann, MW

“…Abstract only…”
Get full text